Department of Political Science, McMaster University, Canada.
Department of Human Development and Applied Psychology, Ontario Institute for Studies in Education, University of Toronto, Canada.
Vaccine. 2024 Jan 25;42(3):505-511. doi: 10.1016/j.vaccine.2023.12.073. Epub 2024 Jan 3.
Since the approval of SARS-CoV-2 vaccines for younger children (those under the age of 12), uptake has been low. Despite widespread vaccination among older children and adults, these trends may undermine public health efforts to manage future waves of SARS-CoV-2 or spill over into other childhood vaccines. The objectives of this study were to understand parents' intentions to vaccinate their children (under age 12) against SARS-CoV-2, and to explore reasons for and against SARS-CoV-2 vaccination.
A representative sample of parents of school-aged children (ages 3-11 years) from Canada's four largest provinces were invited in June 2021 to complete a survey on the impact of COVID-19 on schooling. The survey included specific questions on parents' intentions to vaccinate their child(ren) against SARS-CoV-2. Multinomial regression models were run to estimate associations between demographic factors, political affiliation and voting, concerns about individual / family health and vaccination intention.
A total of 74.0 % of parents (n = 288) intended to vaccinate their children with the SARS-CoV-2 vaccine, 18.3 % (n = 71) did not intend to vaccinate and 7.7 % (n = 30) were unsure. The strongest predictor of parental hesitancy was whether a parent had themselves been vaccinated. Other factors including past voting behaviour, dissatisfaction with the government's response to the pandemic, and relatively less concern about contracting SARS-CoV-2 were also correlated with hesitancy. Parents of older children were more likely to indicate plans to vaccinate their child(ren). Analysis of the reasons for hesitancy showed parents are concerned about the safety and side effects of the vaccine, as well as with processes of testing and approval.
A considerable proportion of Canadian parents of younger school-aged children (ages 3-11) were unsure and/or hesitant about vaccinating their children against SARS-CoV-2. As well, a much larger proportion who are not necessarily hesitant have also not had their children vaccinated. Given the evolving nature of SARS-CoV-2, including the continued emergence of new variants, reaching younger children will be important for population health. Health providers should continue to work with government institutions to ensure clear communication regarding the safety, efficacy, and importance of child vaccines for reaching public health goals.
自 SARS-CoV-2 疫苗获准用于年龄较小的儿童(12 岁以下)以来,疫苗接种率一直较低。尽管大龄儿童和成年人广泛接种了疫苗,但这些趋势可能会破坏管理未来 SARS-CoV-2 浪潮或溢出到其他儿童疫苗的公共卫生努力。本研究的目的是了解父母对其子女(12 岁以下)接种 SARS-CoV-2 疫苗的意愿,并探讨接种 SARS-CoV-2 疫苗的原因和反对意见。
2021 年 6 月,从加拿大四个最大省份邀请了学龄儿童(3-11 岁)的父母代表样本完成了一项关于 COVID-19 对学校教育影响的调查。该调查包括父母对其子女接种 SARS-CoV-2 疫苗的意图的具体问题。使用多项回归模型来估计人口统计学因素、政治派别和投票、对个人/家庭健康的担忧与接种意愿之间的关联。
共有 74.0%的父母(n=288)打算为其子女接种 SARS-CoV-2 疫苗,18.3%(n=71)不打算接种疫苗,7.7%(n=30)不确定。父母犹豫不决的最强预测因素是父母本人是否接种过疫苗。其他因素,包括过去的投票行为、对政府应对大流行的不满,以及对感染 SARS-CoV-2 的相对较少的担忧,也与犹豫不决有关。年龄较大的孩子的父母更有可能表示计划为其子女接种疫苗。对犹豫不决原因的分析表明,父母担心疫苗的安全性和副作用,以及测试和批准过程。
相当一部分加拿大年龄较小的学龄儿童(3-11 岁)的父母对为其子女接种 SARS-CoV-2 疫苗不确定和/或犹豫不决。同样,还有相当一部分并非犹豫不决的父母也没有为子女接种疫苗。考虑到 SARS-CoV-2 的不断演变,包括新变体的持续出现,为年幼的儿童接种疫苗对于人口健康非常重要。卫生保健提供者应继续与政府机构合作,确保就儿童疫苗的安全性、有效性和重要性进行清晰沟通,以实现公共卫生目标。